Read the quarter in context.
A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹4,244 Cr
verified against source
Revenue YoY
19.1%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
BEL reported a strong Q1 FY25 with revenue of INR 4,105 crore (+19.1% YoY) and PAT of INR 776 crore (+46.2% YoY), driven by robust execution across defense programs like LRSAM and CBIC. EBITDA margin expanded to 22.82% (+354 bps YoY), aided by operating leverage. Management maintained full-year guidance of 15% revenue growth, 23-25% EBITDA margin, and INR 25,000 crore order inflow. The order book stood at INR 76,705 crore as of July 31, providing strong visibility. Key near-term catalysts include QRSAM (expected >INR 25,000 crore in FY26) and other large programs. Risk: supply chain disruptions from Israel or Russia could impact execution timelines.
Colored figures show movement against the previous available record.
Guidance to track
- Management reaffirmed 15% revenue growth guidance for the full year, despite Q1 growth of 19.1%.
- EBITDA margin guidance maintained at 23-25% for the full year, with gross margin expected at 40-42%.
- Order inflow guidance maintained at INR 25,000 crore for the current fiscal year.
- QRSAM order expected to be >INR 25,000 crore, likely in Q1 FY26.
Risks flagged
- Past disruptions due to Israel war impacted execution; management noted improvement but risks remain.
- Management acknowledged that component-level indigenization will take 5-10 years, posing dependency on imports.
- Kavach system will take 18-24 months to start generating revenue, delaying a large opportunity.
- Provision for LD and doubtful debts rose to INR 132 crore from INR 54 crore YoY, impacting other expenses.
Key quotes
- We would like to maintain the guidance we have given already in our previous con call, which will be 15%. So, revenue growth will be around 15% compared to last year.
- If QRSAM comes, definitely it will be additional, around INR 20,000 crore-INR 25,000 crore.
- The revenue growth of 15%, the EBITDA margin of 23%-25%, and order inflow of minimum INR 25,000 crore. So these three, definitely, we are giving further guidance or reassuring that we are going to achieve these targets in this year.
Research modules